Document Detail


Slow developing pressor effect of angiotensin II and vascular structure.
MedLine Citation:
PMID:  8315515     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To summarize and discuss four experiments relating to a possible action of angiotensin (Ang) II as a vascular growth factor and to consider the importance of growth factors in hypertension. EXPERIMENT 1: Rats infused with a low dose of Ang II developed a slow pressor response. After 10 days vascular hypertrophy was evident. Other rats infused with Ang II and given hydralazine to prevent the rise in pressure also developed vascular hypertrophy. EXPERIMENT 2: The results of a second experiment suggested that Ang II caused vascular hypertrophy by a mechanism that involves the proto-oncogene c-fos, an intermediary in growth factor action. EXPERIMENT 3: In this experiment hypophysectomy arrested maturation of resistance vessels in the rat and prevented the structural vascular response to increased arterial pressure. Thyroxine and growth hormone prevented both these effects, presumably acting as growth factors. EXPERIMENT 4: In the fourth experiment, young spontaneously hypertensive rats (SHR) given an angiotensin converting enzyme (ACE) inhibitor for 4 weeks did not fully develop hypertension, even after the ACE inhibition had ceased. This effect was prevented by the infusion of Ang II during the ACE inhibition. These results suggest that the blood pressure rise in SHR has a reversible element related to Ang II.
CONCLUSIONS: Ang II causes vascular hypertrophy by a non-pressor mechanism, possibly as a growth factor. Ang II and other growth factors may be important in the development of a normal vascular system and of abnormal vessels in hypertension.
Authors:
A F Lever
Related Documents :
2839205 - Potent depressor action of leumorphin, a kappa-opioid agonist, in conscious rats.
20448215 - Therapeutic targeting of mitochondrial superoxide in hypertension.
19652765 - Angiotensin ii type 1 receptor blockers reduce urinary angiotensinogen excretion and th...
3468805 - Central angiotensin ii and pge2 act independently to increase blood pressure in conscio...
12846625 - A comparison of the effect of two anaesthetic techniques on surgical conditions during ...
11958385 - Small and large artery elasticity indices in peripheral arterial occlusive disease (paod).
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of hypertension. Supplement : official journal of the International Society of Hypertension     Volume:  11     ISSN:  0952-1178     ISO Abbreviation:  J Hypertens Suppl     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-07-29     Completed Date:  1993-07-29     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  8501422     Medline TA:  J Hypertens Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  S27-8     Citation Subset:  IM    
Affiliation:
MRC Blood Pressure Unit, Western Infirmary, Glasgow, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / physiology*
Animals
Blood Vessels / pathology*
Growth Substances / physiology*
Hypertension / pathology*,  physiopathology
Hypertrophy / physiopathology
Rats
Rats, Inbred SHR
Chemical
Reg. No./Substance:
0/Growth Substances; 11128-99-7/Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldost...
Next Document:  The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy.